Unknown

Dataset Information

Biomarkers and Lung Cancer Early Detection: State of the Art.


ABSTRACT: Lung cancer burden is increasing, with 2 million deaths/year worldwide. Current limitations in early detection impede lung cancer diagnosis when the disease is still localized and thus more curable by surgery or multimodality treatment. Liquid biopsy is emerging as an important tool for lung cancer early detection and for monitoring therapy response. Here, we reviewed recent advances in liquid biopsy for early diagnosis of lung cancer. We summarized DNA- or RNA-based biomarkers, proteins, autoantibodies circulating in the blood, as well as circulating tumor cells (CTCs), and compared the most promising studies in terms of biomarkers prediction performance. While we observed an overall good performance for the proposed biomarkers, we noticed some critical aspects which may complicate the su

SUBMITTER: Dama E 

PROVIDER: S-EPMC8345487 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature